Overview
- Lawmakers passed the bill in its first reading on January 13, advancing a proposal from United Russia deputies and senators that previously received government support.
- The experiment is scheduled from June 1, 2026 to June 1, 2029 and permits licensed pharmacy organizations to sell medicines via mobile units only in settlements without existing pharmaceutical providers.
- Sales from mobile points will exclude drugs containing narcotics, psychotropic or strong-acting substances, radiopharmaceuticals, immunobiologicals, products with over 25% alcohol, and medicines requiring storage below 15°C.
- Regions will join the program by Russian government order upon a petition from the regional head, and participation will exclude cities of federal significance.
- Technical standards will be set by the Health Ministry; a Krasnoyarsk-built GAZ ‘Gazelle’ prototype has been demonstrated, and officials say one unit could serve up to 50 assigned locations.